98%
921
2 minutes
20
Introduction: The current study examined the efficacy of the 10-session Kessler Foundation modified Story Memory Technique (KF-mSMT) to improve new learning in older adults.
Methods: This double-blind, placebo-controlled randomized clinical trial included twenty-eight individuals over age 65 randomized to the treatment group ( = 17) or placebo control group ( = 13). Participants completed a baseline neuropsychological assessment, including questionnaires assessing everyday memory, and a repeat assessment immediately post-treatment. The primary outcome measure was the total learning score from the California Verbal Learning Test II (CVLT-II) and the secondary outcome measure was the total score from the Memory Functioning Questionnaire.
Results: A significant effect of the KF-mSMT was noted on the CVLT-II total learning score in the treatment group, demonstrating a large effect size. Post hoc analysis examining benefit from the KF-mSMT in the healthy aging group as compared with the mild cognitive impairment (MCI) group showed a trend toward significance ( = 0.069), with a large effect size. With benefit defined as a 10% or greater improvement in the CVLT total learning, 65% of patients in the treatment group showed improvement from baseline to immediate follow-up, compared with 31% of the control group ( = 0.06). Significant treatment effects were also noted in a self-report measure of memory in daily life, the Memory Functioning Questionnaire. Post-treatment changes in depression or anxiety from before to after treatment were not significant between the groups.
Conclusion: The current study presents preliminary evidence in support of the KF-mSMT for improving learning and memory abilities in older populations of those aging normally and those meeting criteria for MCI.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11908804 | PMC |
http://dx.doi.org/10.1159/000543682 | DOI Listing |
Anat Rec (Hoboken)
September 2025
Department of Anatomy, Midwestern University, Glendale, Arizona, USA.
Canids originally evolved in North America, presenting a compelling story of shifting climates, paleogeographies, and both successes and failures in adapting to these changes. Species evolve-new ones arrive on the scene and established ones become extinct. The dire wolf (Aenocyon dirus) is one of the most legendary of the extinct canids and is the most basal member of the crown group of large dogs (Canina) that includes the extant gray wolf (Canis lupus).
View Article and Find Full Text PDFHead Neck
September 2025
Department of Otolaryngology-Head and Neck Surgery, Western University, London, Ontario, Canada.
Background: Salvage surgery (SS) is one of the best treatment options for recurrent oropharyngeal squamous cell carcinoma (OPSCC) after prior definitive radiation.
Methods: A Medline literature search of articles on open (OSS) and transoral robotic surgery (TORS) for the treatment of recurrent OPSCC was performed. Surgical, functional, and oncological outcomes were analyzed and compared.
Nanotoxicology
September 2025
Department of Biophysics of Environmental Pollution, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
The effect of non-functionalized polystyrene nanoparticles (PS-NPs) with diameters of 29, 44, and 72 nm on plasmid DNA integrity and the expression of genes involved in the architecture of chromatin was investigated in human peripheral blood mononuclear cells (PBMCs). The cells were incubated with PS-NPs at concentrations ranging from 0.001 to 100 µg/mL for 24 hours.
View Article and Find Full Text PDFPediatr Transplant
November 2025
Division of Urology, University of Toronto, Toronto, Canada.
Introduction: Differentiating acute tubular necrosis (ATN) from rejection in pediatric kidney transplant (KT) recipients remains challenging and necessitates invasive biopsy. Doppler ultrasound-derived resistive index (RI) is a noninvasive modality to assess graft status, but its diagnostic utility in children is unclear. This study evaluates RI's ability to distinguish ATN and rejection in KT.
View Article and Find Full Text PDFStroke
September 2025
Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. (V.Y., B.C.V.C., L.C., L.O., M.W.P.).
Background: To assess the efficacy and safety of tenecteplase in patients presenting within 24 hours of symptom onset with a large vessel occlusion and target mismatch on perfusion computed tomography.
Methods: ETERNAL-LVO was a prospective, randomized, open-label, blinded end point, phase 3, superiority trial where adult participants with a large vessel occlusion, presenting within 24 hours of onset with salvageable tissue on computed tomography perfusion, were randomized to tenecteplase 0.25 mg/kg or standard care across 11 primary and comprehensive stroke centers in Australia.